Consequently, metabolic endotoxemia—persistently elevated circulating LPS levels—activates Toll-like receptor-4 (TLR4), an immune receptor that recognizes endotoxins, triggering NF-κB inflammation, signaling, and downstream inflammatory cascades, fostering systemic insulin resistance [11]. This evidence concerns the gene TLR4 and serum lipopolysaccharide activity.